以TFEB为媒介的自刺激作为骨的合成药物策略:从骨质母细胞系中TFEB激活的洞察力
Melda Onal1,2
1Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Autophagy reports
|December 11, 2025
概括
在骨细胞中通过转录因子EB (Tfeb) 刺激自会促进骨的形成和强度. 这表明Tfeb激活是治疗骨质疏松症和其他骨疾病的潜在疗法.
科学领域:
- 骨生物学 骨生物学 骨生物学
- 细胞生物学 细胞生物学
- 代谢途径 代谢途径
背景情况:
- 自对于骨形成和骨平衡至关重要.
- 自支持骨形成的确切机制尚未完全理解.
研究的目的:
- 为了研究骨形成过程中自的机制.
- 为了评估刺激骨自的骨代谢的潜力.
主要方法:
- 在骨质细胞系细胞中生成了具有高转录因子EB (Tfeb) 的遗传小鼠模型.
- 利用单细胞RNA测序和体外研究.
主要成果:
- 升高的Tfeb增加了自和溶酶体基因表达,增强了骨质母细胞中的自流.
- 自刺激导致皮质和结骨的骨形成,质量和强度增加.
- 观察到骨质细胞亡减少和骨质细胞扩散增加,导致骨质细胞数量增加.
- 增强了骨质母细胞功能,包括细胞外骨基质的产生.
结论:
- 在骨质母细胞中提升Tfeb刺激了自,促进了骨的形成,增强了骨质和强度.
- 作为治疗骨质疏松症的治疗策略,TFEB激活值得进一步研究.
相关概念视频
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


